CN116726408A - Laser system for treating chest and abdomen infection and application method thereof - Google Patents
Laser system for treating chest and abdomen infection and application method thereof Download PDFInfo
- Publication number
- CN116726408A CN116726408A CN202310715517.8A CN202310715517A CN116726408A CN 116726408 A CN116726408 A CN 116726408A CN 202310715517 A CN202310715517 A CN 202310715517A CN 116726408 A CN116726408 A CN 116726408A
- Authority
- CN
- China
- Prior art keywords
- treatment
- laser
- optical fiber
- light
- image transmission
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000015181 infectious disease Diseases 0.000 title claims abstract description 51
- 210000001015 abdomen Anatomy 0.000 title claims abstract description 29
- 238000000034 method Methods 0.000 title claims abstract description 16
- 239000013307 optical fiber Substances 0.000 claims abstract description 85
- 230000003187 abdominal effect Effects 0.000 claims abstract description 4
- 238000011282 treatment Methods 0.000 claims description 164
- 230000005540 biological transmission Effects 0.000 claims description 36
- 230000001225 therapeutic effect Effects 0.000 claims description 30
- 239000000835 fiber Substances 0.000 claims description 29
- 230000000007 visual effect Effects 0.000 claims description 15
- 238000005286 illumination Methods 0.000 claims description 13
- 239000000463 material Substances 0.000 claims description 5
- 238000012800 visualization Methods 0.000 claims description 4
- 239000011521 glass Substances 0.000 claims description 3
- 229910052594 sapphire Inorganic materials 0.000 claims description 3
- 239000010980 sapphire Substances 0.000 claims description 3
- 206010057751 Post procedural discharge Diseases 0.000 claims description 2
- 239000012782 phase change material Substances 0.000 claims description 2
- 210000000038 chest Anatomy 0.000 abstract description 20
- 210000000115 thoracic cavity Anatomy 0.000 abstract description 6
- 210000000056 organ Anatomy 0.000 abstract description 4
- 210000004872 soft tissue Anatomy 0.000 abstract description 4
- 210000000683 abdominal cavity Anatomy 0.000 abstract description 2
- 230000035876 healing Effects 0.000 abstract 1
- 230000017423 tissue regeneration Effects 0.000 abstract 1
- 244000052769 pathogen Species 0.000 description 8
- 230000000694 effects Effects 0.000 description 6
- 238000003384 imaging method Methods 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 241000700605 Viruses Species 0.000 description 4
- 230000007797 corrosion Effects 0.000 description 4
- 238000005260 corrosion Methods 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 230000002147 killing effect Effects 0.000 description 4
- 230000003833 cell viability Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010017533 Fungal infection Diseases 0.000 description 2
- 208000034486 Multi-organ failure Diseases 0.000 description 2
- 208000031888 Mycoses Diseases 0.000 description 2
- 206010035737 Pneumonia viral Diseases 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 206010062255 Soft tissue infection Diseases 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 229920002313 fluoropolymer Polymers 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 210000004211 gastric acid Anatomy 0.000 description 2
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000001678 irradiating effect Effects 0.000 description 2
- 238000005399 mechanical ventilation Methods 0.000 description 2
- 208000029744 multiple organ dysfunction syndrome Diseases 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 229920000767 polyaniline Polymers 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 210000003437 trachea Anatomy 0.000 description 2
- 208000009421 viral pneumonia Diseases 0.000 description 2
- JJTUDXZGHPGLLC-IMJSIDKUSA-N 4511-42-6 Chemical compound C[C@@H]1OC(=O)[C@H](C)OC1=O JJTUDXZGHPGLLC-IMJSIDKUSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- 241001678559 COVID-19 virus Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 206010060803 Diabetic foot infection Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 206010017472 Fumbling Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
- 208000010718 Multiple Organ Failure Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 229920001244 Poly(D,L-lactide) Polymers 0.000 description 1
- 206010050404 Retroperitoneal infection Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 210000003445 biliary tract Anatomy 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 230000002900 effect on cell Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000000642 iatrogenic effect Effects 0.000 description 1
- 238000002356 laser light scattering Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000012994 photoredox catalyst Substances 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 210000000574 retroperitoneal space Anatomy 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Landscapes
- Radiation-Therapy Devices (AREA)
Abstract
The application relates to the technical field of optical fiber medical equipment, and particularly discloses a laser system and a method for treating chest and abdomen infection. The laser system irradiates the part to be treated, so that the infection of the thoracic and abdominal organs, the thoracic and abdominal cavities and deep soft tissues can be treated, and the tissue repair and healing of the part to be treated are promoted.
Description
Technical Field
The application relates to the technical field of optical fiber medical equipment, in particular to a laser system for treating chest and abdomen infection and a using method thereof.
Background
The development of medical and health industry ensures the health of people greatly, but serious and complicated infection still endangers the lives of people seriously. Infectious pathogens include infections with multiple resistant bacteria or pan resistant bacteria, infections with specific pathogens, infections with bacteria or viruses that are temporarily devoid of specific drugs, certain fungal infections, or infections caused by insufficient drug permeability in specific sites such as packaging, or infections caused by severe adverse drug reactions affecting their clinical use, or infections that are not rapidly reversible so as to shock or multiple organ failure, which can seriously threaten patient life. The chest and abdomen infection is a common part of weight symptoms or complex infections, and often the patients are in an infection state, multi-organ failure, shock and the like for a long time due to the conditions, so that the life quality and clinical prognosis of the patients are seriously affected.
The laser fiber is widely used for laser conduction in various industries at present, is generally used for illumination and image conduction of an internal cavity channel in the field of medical and health, for example, illumination light beams and image conduction light beams used in a gastroscope are all completed by using the laser fiber, for example, illumination light beams and image conduction light beams of a laparoscope are also completed by using the laser fiber, and other forms of endoscopes are also provided, the principle of which is the same as that of a gastroscope laparoscope, but no one has used the laser fiber for conducting laser to treat pleuroperitoneal infectious lesions in vivo directly.
In the prior art, a technology of using red blue light to irradiate the body surface exists, which is used for clinically promoting the recovery of affected tissues of the body surface infection, such as diabetic foot infection, acne, light pneumonia and the like, but clinical application research of irradiating affected parts of the infection by light of different wave bands in the body is not yet seen.
Disclosure of Invention
In order to overcome the treatment difficulty of the chest and abdomen infection in the prior art, the application provides a laser system for treating the chest and abdomen organ, the chest and abdomen and deep soft tissue infection and a use method thereof, and the treatment is carried out by using treatment light with different wavelengths to irradiate pathological tissues in the body.
The technical scheme adopted by the application is as follows:
a laser system for treating chest and abdomen infections, the laser system comprising a treatment carrier, a treatment fiber, a laser transmitter, an image transmission system and a visualization screen,
the treatment carrier is arranged in the body cavity or the cavity channel, the treatment optical fiber can enter and exit the treatment carrier, the treatment carrier is withdrawn after reaching the part to be treated by the treatment carrier,
the treatment optical fiber is connected with the laser emitter and the image transmission system, the image transmission system is connected with the visual screen,
the laser transmitter provides therapeutic light and illumination light required by the therapeutic optical fiber, and the image transmission system receives the image of the part to be treated in real time through the therapeutic optical fiber and displays the image on a visual screen.
Further, the treatment optical fiber comprises a tail end connector, an optical fiber main body and a head irradiation end, wherein the tail end connector is connected with the laser diffuser and the image transmission system, and the head irradiation end is provided with a laser diffusion mirror which is used for diffusing treatment light.
Further, the head end of the laser scattering mirror is arranged as a terminal hemispherical short cylinder or hemispherical long cylinder, and the length L of the hemispherical short cylinder 1 Less than or equal to 3mm and is made of sapphire glass, and the length L of the hemispherical long cylinder is less than or equal to 3mm 2 Is 0.5-2cm and is made of flexible phase change material.
Further, the inside of optic fibre main part includes laser input optic fibre and image transmission optic fibre, laser input optic fibre sets up to many, many laser input optic fibre can carry out the irradiation of multiple therapeutic light simultaneously or carry out the irradiation of therapeutic light or illumination light in proper order, image transmission optic fibre can return the therapeutic light signal to image transmission system and be used for confirming, adjustment therapeutic optic fibre position or observe the treatment position.
Preferably, the external surface of the treatment optical fiber is made of a biological inert material, which can resist corrosion and potential chemical reaction of body fluid or secretion such as gastric acid, intestinal juice and the like, has smooth surface, is wear-resistant, resists corrosion of disinfectant such as alcohol, formaldehyde, hypochlorous acid and the like, has moderate flexibility and hardness, and can be bent moderately so as to be convenient for entering and exiting the treatment carrier.
Preferably, the length of the treatment optical fiber is greater than the length of the treatment carrier, and the length of the treatment optical fiber is greater than twice the length of the carrier, so that the treatment optical fiber is convenient to be withdrawn gradually after being properly fixed by holding the part of the treatment optical fiber, which is longer than the treatment carrier, after the treatment optical fiber is sent into the treatment part of the cavity by the treatment carrier.
Preferably, in order to meet the requirement that the treatment carrier is withdrawn smoothly, the connection position of the main body and the end part of the treatment optical fiber is smaller than or equal to the diameter of the optical fiber bundle, and the diameter of the treatment optical fiber is 1-3nm.
Preferably, the treatment carrier comprises common medical equipment and invasive cavity pipelines, the common medical equipment comprises bronchoscopes, gastroscopes, enteroscopes, thoracoscopes, laparoscopes and the like, and the invasive cavity pipelines comprise transnasal oral trachea cannula, tracheotomy cannula, thoracic drainage tube, abdominal drainage tube, postoperative drainage pipelines and the like.
Further, the laser emitter can simultaneously or sequentially emit different therapeutic lights with different wavelengths to the laser input optical fibers corresponding to the therapeutic optical fibers, wherein the therapeutic lights comprise blue lights with wavelengths of 400-480nm, red lights with wavelengths of 620-740nm, yellow lights with wavelengths of 570-600nm and the like, and the types and the wavelengths of the specific therapeutic lights are selected and determined according to the conditions of the to-be-treated part.
The application also provides another technical scheme:
a method for using a laser system for treating chest and abdomen infections, wherein the laser system is described in the technical scheme, and the specific method for using the laser system is implemented according to the following steps:
s1: delivering the treatment optical fiber to the part to be treated by means of the treatment carrier;
s2: starting a laser emitter, emitting an illumination light source, and determining or adjusting the position of the treatment optical fiber through an image on a visual screen of an image transmission system;
s3: determining treatment parameters, and adjusting the laser emitter to emit treatment light to irradiate the part to be treated;
s4: adjusting the treatment part by means of an image transmission system or a treatment carrier, and repeating the step S3 until all treatments are completed;
s5: and (5) withdrawing the treatment optical fiber, and ending the treatment.
Further, after the treatment optical fiber is delivered to the treatment site, the treatment carrier is selected to be withdrawn or not withdrawn according to the type of the treatment carrier, the treatment carrier can be withdrawn when the treatment carrier is common medical equipment, and the treatment carrier is not withdrawn when the treatment carrier is invasive cavity channel.
Further, the treatment parameters in the step S3 include: the wavelength, type, irradiation frequency, irradiation power, and irradiation time of the therapeutic light, and the determination of the therapeutic parameters are selected according to the therapeutic scheme, and the adjustment and variation can be performed according to the actual situation.
Preferably, the therapeutic light comprises blue light with a wavelength of 400-480nm, red light with a wavelength of 620-740nm, yellow light with a wavelength of 570-600nm, and the like, the irradiation power of the blue light is 0-200mW/cm < 2 >, the irradiation power of the red light and the yellow light is 0-250mW/cm < 2 >, and the irradiation duration of the therapeutic light is controlled within 60 minutes.
The application has at least the following beneficial effects:
1. the laser system for treating the chest and abdomen infection provided by the application has the advantages that the laser emitter irradiates treatment light such as red and blue light or yellow light on the part to be treated through the treatment optical fiber, so that the effects of promoting the repair of pathological tissues, enhancing local immunity, killing and inhibiting pathogens are achieved, and the chest and abdomen infection and deep soft tissue infection can be effectively treated;
2. the laser system for treating the chest and abdomen infection provided by the application utilizes the treatment carrier to send the treatment optical fiber into the body cavity or the cavity channel, and simultaneously is matched with the image transmission system to position the treatment optical fiber, wherein the treatment carrier adopted in the application is common clinical medical equipment or invasive cavity channel pipelines, so that the laser system can perform operation and reduce iatrogenic adverse reactions;
3. the application method of the laser system for treating chest and abdomen infection provided by the application can adjust the treatment parameters in real time according to the condition of the part to be treated, and the whole operation is flexible and can be completed efficiently.
Drawings
FIG. 1 is a schematic diagram of a laser system for treating chest and abdomen infections according to the present application;
FIG. 2 is a schematic view of a therapeutic optical fiber structure of a laser system for treating chest and abdomen infections according to the present application;
fig. 3 is a flow chart of a method of using a laser system for treating chest and abdomen infections according to the present application.
Description of the reference numerals: 1. a treatment optical fiber; 2. a visual screen; 3. a laser emitter; 4. an image transmission system; 5. a terminal fitting; 6. an optical fiber main body; 7. a head irradiation end; 8. a laser input optical fiber; 9. an image transmission optical fiber; 10. a laser light scattering mirror.
Detailed Description
For the purpose of making the objects, technical solutions and advantages of the embodiments of the present application more apparent, the technical solutions of the embodiments of the present application will be clearly and completely described below with reference to the accompanying drawings in the embodiments of the present application, and it is apparent that the described embodiments are some embodiments of the present application, but not all embodiments of the present application. All other embodiments, which can be made by those skilled in the art based on the embodiments of the application without making any inventive effort, are intended to be within the scope of the application.
Example 1
Referring to fig. 1 and 2, the application discloses a laser system for treating chest and abdomen infection, which comprises a treatment carrier, a treatment optical fiber 1, a visual screen 2, a laser emitter 3 and an image transmission system 4, wherein the treatment carrier can enter a cavity of a body to be treated or is arranged in the cavity, the treatment optical fiber 1 can enter and exit the treatment carrier, the treatment carrier is withdrawn after reaching a part to be treated by the treatment carrier,
the treatment optical fiber 1 is connected with the laser emitter 3 and the image transmission system 4, the image transmission system 4 is connected with the visualization screen 2, the laser emitter 3 provides treatment light and illumination light required by the treatment optical fiber 1, the image transmission system 4 receives images of the part to be treated through the treatment optical fiber 1 in real time and is displayed on the visualization screen 2 for determining, adjusting the position of the treatment optical fiber or observing the treatment part,
the treatment optical fiber 1 comprises a terminal connector 5, an optical fiber main body 6 and a head irradiation end 7, wherein the terminal connector 5 is connected with the laser emitter 3 and the image transmission system 4, the head irradiation end 7 is provided with a laser scattering mirror 10, the laser scattering mirror 10 is used for scattering and diffusing treatment light, the head end of the laser scattering mirror 10 is arranged into a terminal hemispherical short cylinder with the length of 3mm and is formed by processing sapphire glass, the inside of the optical fiber main body 6 comprises a plurality of laser input optical fibers 8 and an image transmission optical fiber 9, the plurality of laser input optical fibers 8 can simultaneously irradiate a plurality of treatment lights or sequentially irradiate a plurality of treatment lights or irradiate illumination lights,
the external surface of the treatment optical fiber 1 is made of biological inert materials including but not limited to polycarbonate PC, polymethyl methacrylate PMMA, L-lactide PDLLA, fluorinated polymer CYTOP, polyaniline PANI, polyurethane, fluoroplastic resin and other biological inert materials with processing prospect, the materials can resist corrosion and potential chemical reaction of body fluid or secretion such as gastric acid, intestinal juice and the like, the surface is smooth and wear-resistant, resist corrosion of disinfectant such as alcohol, glutaraldehyde, hypochlorous acid and the like, and the treatment optical fiber 1 has moderate flexibility and hardness, can be moderately bent to facilitate entering and exiting the inside of the treatment carrier, the length of the treatment optical fiber 1 is longer than the length of the treatment carrier, the length of the treatment optical fiber 1 is longer than twice the length of the carrier, the section of the treatment optical fiber 1 is cylindrical, the treatment optical fiber 1 has smaller diameter and can be freely inserted into the treatment carrier, and the body can not be damaged after being poured to the part to be treated,
with reference to fig. 3, the laser system is used for treating chest and abdomen infection, and the specific use method of the laser system is as follows:
s1: delivering the treatment optical fiber to the part to be treated by means of the treatment carrier;
s2: starting a laser emitter, emitting an illumination light source, and determining or adjusting the position of the treatment optical fiber through an image on a visual screen of an image transmission system;
s3: determining treatment parameters, and adjusting the laser emitter to emit treatment light to irradiate the part to be treated;
s4: adjusting the treatment part by means of an image transmission system or a treatment carrier, and repeating the step S3 until all treatments are completed;
s5: and (5) withdrawing the treatment optical fiber, and ending the treatment.
The treatment parameters in step S3 include: the wavelength, type, irradiation frequency and irradiation time of the therapeutic light, and the determination of the therapeutic parameters are selected according to the therapeutic scheme, and the adjustment and variation can be performed according to the actual situation.
In the laser system and the method for treating chest and abdomen infection, disclosed by the application, the treatment optical fiber is delivered to the part to be treated by means of common medical equipment and invasive cavity pipelines, and different types of treatment lights with different wavelengths are emitted by the laser emitter to carry out irradiation treatment, so that the purposes of promoting the repair of pathological tissues and enhancing local immunity are achieved.
Example two
The embodiment discloses a laser system for treating chest and abdomen infection, which is the same as the laser system in the first embodiment, and is different in that a safety control system is further added at the laser emitter 3, and the safety control system comprises a temperature control system, a wavelength control system and a power control system;
the temperature control system can monitor the temperature of the laser emitter in real time and display the temperature on a visual screen in real time, controls the temperature of the laser emitter in a certain range, and comprises a cooling system for controlling the steady-state fluctuation range of the laser emitter to be not more than 10 ℃ according to the real-time temperature, sending a warning when the steady-state fluctuation range of the laser emitter exceeds 10 ℃, forcibly turning off the laser emitter when the steady-state temperature fluctuation range of the laser emitter exceeds 15 ℃,
the wavelength control system can directly monitor the wavelength of the therapeutic light emitted by the laser emitter, and display the wavelength on the visual screen in real time so as to prevent the wavelength of the therapeutic light from greatly drifting when the laser emitter fails, and finally control the change of the wavelength of the therapeutic light to float up and down by 2nm, when the wavelength drifting exceeds 2nm, the wavelength control system gives out a warning, when the wavelength drifting exceeds 10nm, the wavelength control system cuts off the laser emission,
the power control system is used for controlling the transmitting power of the laser transmitter, monitoring peak power and average power in real time and displaying the peak power and the average power on a visual screen, and sending out a warning when the average power exceeds 5% of the set power and forcibly turning off the laser transmitter when the average power exceeds 10%.
The intelligent control degree of the laser transmitter is further improved through the arrangement, the safety control system is increased, the use safety of the laser transmitter can be effectively realized through comprehensive regulation and control of temperature, wavelength and power, the safety of the laser system is improved, and the light source in the accurate and complex environment in the human body is further ensured to be controllable.
Example III
In this embodiment, a patient with severe mechanical ventilation viral pneumonia is used as a treatment object, and the laser system described in the embodiment is used, and in this embodiment, a fiber bronchoscope is used as a treatment carrier, and specific treatment steps are as follows:
s1: performing conventional preparation before operation of the fiber bronchoscope, and performing preparation checking and checking on a treatment optical fiber, a laser and an image transmission system and a visual screen;
s2: the fiber bronchoscope enters the airway along the trachea cannula, is positioned according to imaging guidance such as CT and the like, reaches the most distal end of the treatment part, and is fixed;
s3: inserting the treatment optical fiber into the cavity of the fiber bronchoscope, gradually introducing the treatment optical fiber, and placing the head irradiation end of the treatment optical fiber at the treatment position after exiting the endoscope cavity of the fiber bronchoscope;
s4: gradually withdrawing the fiber bronchoscope according to the surface scales of the endoscope cavity and the treatment optical fiber until the tail end of the endoscope breaks away from the tracheal cannula, fixing the treatment optical fiber, completely withdrawing the bronchoscope, and reserving the treatment optical fiber;
s5: connecting a treatment optical fiber with a laser emitter and an image imaging system, firstly emitting an illumination light source, comparing with the imaging under a fiber bronchoscope, evaluating the position of the tail end of the treatment optical fiber again according to a real-time image of a visual screen and adjusting the position moderately, then emitting blue light and red light for imaging, and observing imaging characteristics before treatment;
s6: firstly, turning on blue light irradiation, adjusting a laser emitter, emitting blue light with wavelength of 430nm, and adjusting power density to 40mW/cm 2 The irradiation time is 30 minutes, then the red light is irradiated, the red light with the wavelength of 630nm is emitted, and the power density is adjusted to 100mW/cm 2 The irradiation time is 20 minutes, and a probe light source can be started at any time to observe and evaluate the change of the treatment part during or after irradiation;
s7: changing the treatment part, observing the imaging of the visual screen through a real-time image transmission system, slowly withdrawing the treatment optical fiber, paying attention to the withdrawing range, adjusting the position of the treatment optical fiber, and repeating the step 6 until the irradiation treatment of all the treatment parts is completed;
s8: and (3) ending the treatment, gradually exiting the treatment optical fiber from the airway under the observation of the real-time image transmission system, closing the laser transmitter and the image transmission system, and disconnecting the optical fiber.
Before treatment, the local pathological changes of the airway, such as mucosa inside diameter, edema, hemorrhage and the like, can be evaluated by a fiber bronchoscope, and the wavelength, frequency, intensity and time of the red-blue light treatment are determined according to the clinical comprehensive conditions and the disease evolution of patients;
when the treatment part is replaced in the step S7, when the treatment part needs to be adjusted in a large range, the laser emitter and the image transmission system can be standby again by means of the treatment carrier, the treatment optical fiber terminal connector is disconnected, the treatment optical fiber is led into the fiber bronchoscope cavity, and the steps S2, S3 and S4 are repeated for positioning and then the fiber bronchoscope is withdrawn.
In this embodiment, the patient with severe viral pneumonia caused by mechanical ventilation is treated by using a fiberbronchoscope as a treatment carrier, but other types of infections of the pleuroperitoneal cavity, infections of the pleuroperitoneal cavity organs or deep soft tissue can be treated by using the laser system disclosed by the application, and the laser system disclosed by the application is used for invasive treatment and is suitable for treating severe or complex infections of the thoracic and abdominal cavity organs, serosal cavities or soft tissue, such as broncho-pulmonary parenchymal infections, thoracic cavity infections, intestinal tract infections, biliary tract systems, perianal soft tissue, peritoneal space, retroperitoneal infections and the like, which can be reached by optical fibers.
Meanwhile, the treatment carrier can be one or more of bronchoscope, gastroscope, enteroscope, thoracoscope, laparoscope, nasal oral tracheal cannula, tracheotomy cannula, thoracic drainage tube, abdominal drainage tube and the like, in actual operation, the wavelength, the type, the irradiation frequency, the irradiation time and the like of treatment light are adjusted and determined according to pathogens infected by patients, infection sites and clinical comprehensive conditions, sensitive pathogens comprise viruses, bacteria, fungi, atypical pathogens and the like, and the sensitive pathogens are also adjusted in time according to clinical parameters in the treatment process.
It is explicitly proposed that, for the present study, the sensitivity of other organisms such as cells, bacteria, viruses and the like to the light source is obviously different and different, so that specific treatment parameters need to be adjusted according to the self situation of the patient.
In the invasive medical treatment, the wavelength, energy, irradiation time and other factors of the light source have great influence on the treatment effect for different in-vivo environments.
For human epithelial cells, blue light was emitted at a wavelength of 405nm at 6mW/cm 2 In the case of direct irradiation for 3 hours, the cell viability was reduced by 25% at 12mW/cm 2 Cell viability was reduced by 50% 3 hours after direct irradiation; blue light at 425nm wavelength at 12mW/cm 2 Cell viability was reduced by less than 20% after 3 hours of direct irradiation; blue light at 425nm wavelength at 12mW/cm 2 Direct irradiation, 2 times daily for 45 minutes for 3 days, had very slight effect on cell activity.
For a bacterial infection environment, the shorter the wavelength, the more killing the pathogen. In order to minimize the damage of short-wavelength blue light to tissue cells, the blue light wavelength is prolonged, and the killing effect is also achieved.
For methicillin-resistant Staphylococcus aureus (MRSA), the blue wavelength is 405-470nm, and the irradiation dose is 0-60J/cm at 470nm 2 The effect on MRSA is dose dependent.
For ESBL+Klebsiella pneumoniae with blue light wavelength of 410+ -10 nm at 150mW/cm 2 The bacterial death amount of 99.9% can be achieved by irradiating for 90 minutes under the power density.
For Pseudomonas aeruginosa, blue light with the wavelength of 410-455nm has killing and inhibiting effects on Pseudomonas aeruginosa. At 410nm at 40mW/cm 2 Has obvious inhibition effect after 30 minutes of irradiation, and the dosage of the composition is 40mW/cm at 455nm 2 The irradiation for 90 minutes shows obvious inhibition, and the inhibition mechanism comprises inhibition of biological fumbling, change of plasmid DNA conformation, influence of beta-galactosidase and catalase activities and the like.
For a virus infection environment, such as SARS-CoV-2 virus, blue light wavelength of 425+ -10 nm is 20mW/cm 2 Half the tissue culture infection dose (TCID 50) was reached for 48 hours on the virus after 30 minutes of irradiation.
For fungal infection environment, blue light wavelength is 405nm at 60mW/cm 2 The irradiation for 90 min can kill Candida albicans, and the blue light wavelength is 405nm at 100mW/cm 2 The aspergillus and spores thereof can be obviously killed after 120 minutes of irradiation.
Thus, in clinical use, the patient needs to be adaptively adjusted according to the specific infection condition, the weight and the stage of the patient.
The foregoing description is only illustrative of the present application and is not intended to limit the scope of the application, and all equivalent structures or equivalent processes or direct or indirect application in other related technical fields are included in the scope of the present application.
Claims (10)
1. A laser system for treating chest and abdomen infections, characterized in that the laser system comprises a treatment carrier, a treatment optical fiber, a laser emitter, an image transmission system and a visualization screen,
the treatment carrier is arranged in the body cavity, the treatment optical fiber can enter and exit the treatment carrier, the treatment carrier is withdrawn after reaching the part to be treated by the treatment carrier,
the treatment optical fiber is connected with the laser emitter and the image transmission system, the image transmission system is connected with the visual screen,
the laser transmitter provides therapeutic light and illumination light with wavelengths required by the therapeutic optical fiber, and the image transmission system receives images of the part to be treated in real time through the therapeutic optical fiber and displays the images on a visual screen.
2. A laser system for treating an infection in the chest and abdomen according to claim 1 wherein the treatment fiber comprises a tip connector, a fiber body and a head irradiation end, the tip connector being connected to a laser diffuser and an image transmission system, the head irradiation end being provided with a laser diffuser for diffusing the treatment light.
3. A laser system for treating chest and abdomen infections according to claim 2 wherein the head end of the laser scattering mirror is provided as a terminal hemispherical short cylinder or a terminal hemispherical long cylinder, the length L of the hemispherical short cylinder 1 Less than or equal to 3mm and is made of sapphire glass, and the length L of the hemispherical long cylinder is less than or equal to 3mm 2 Is 0.5-2cm and is made of flexible phase change material.
4. A laser system for treating a chest and abdomen infection according to claim 3 wherein the interior of the optical fiber body comprises a laser input optical fiber and an image transmission optical fiber, the laser input optical fiber is provided with a plurality of laser input optical fibers, the plurality of laser input optical fibers can simultaneously irradiate a plurality of treatment lights or sequentially irradiate the treatment lights or irradiate the illumination lights, and the image transmission optical fiber can transmit a treatment light signal back to the image transmission system for determining, adjusting the position of the treatment optical fiber or observing the treatment site.
5. A laser system for treating a chest and abdomen infection according to claim 4 wherein the laser transmitter is capable of simultaneously or sequentially transmitting different therapeutic light of different wavelengths to the corresponding laser input fiber of the therapeutic fiber, the therapeutic light comprising blue light of 400-480nm wavelength, red light of 620-740nm wavelength, yellow light of 570-600nm wavelength.
6. A laser system for treating an infection of the chest and abdomen according to claim 5 wherein the treatment fiber is of a biologically inert material and bendable in appearance.
7. A laser system for treating an infection of the chest and abdomen according to claim 1 wherein the length of the treatment fiber is greater than the length of the treatment carrier, the treatment fiber having a diameter of 1-3nm.
8. The laser system for treating a thoracoabdominal infection according to claim 1 wherein the treatment carrier comprises a conventional medical device including bronchoscope, gastroscope, enteroscope, thoracoscope, laparoscope, an invasive cavity line including transnasal orotracheal cannula, tracheostomy cannula, chest drainage tube, abdominal drainage tube, and post-operative drainage line.
9. A method of using the laser system of any one of claims 1-6 for treating chest and abdomen infections, said method comprising the steps of:
s1: delivering the treatment optical fiber to the part to be treated by means of the treatment carrier;
s2: starting a laser emitter, emitting an illumination light source, and determining or adjusting the position of the treatment optical fiber through an image on a visual screen of an image transmission system;
s3: determining treatment parameters, and adjusting the laser emitter to emit treatment light to irradiate the part to be treated;
s4: adjusting the treatment part by means of an image transmission system or a treatment carrier, and repeating the step S3 until all treatments are completed;
s5: and (5) withdrawing the treatment optical fiber.
10. The method of claim 9, wherein the treatment parameters in step S3 include: the wavelength, the type, the irradiation frequency, the irradiation power and the irradiation time period of the therapeutic light.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310715517.8A CN116726408A (en) | 2023-06-16 | 2023-06-16 | Laser system for treating chest and abdomen infection and application method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310715517.8A CN116726408A (en) | 2023-06-16 | 2023-06-16 | Laser system for treating chest and abdomen infection and application method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116726408A true CN116726408A (en) | 2023-09-12 |
Family
ID=87902481
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310715517.8A Pending CN116726408A (en) | 2023-06-16 | 2023-06-16 | Laser system for treating chest and abdomen infection and application method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116726408A (en) |
-
2023
- 2023-06-16 CN CN202310715517.8A patent/CN116726408A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10357661B2 (en) | Medical device and method for internal healing and antimicrobial purposes | |
| US6551346B2 (en) | Method and apparatus to prevent infections | |
| US20130303877A1 (en) | Method and apparatus for the treatment of respiratory and other infections using ultraviolet germicidal irradiation | |
| US10245339B2 (en) | Apparatus and method of sterilizing lumens in medical instruments | |
| JP2023106524A (en) | Method of intra-corporeal ultraviolet treatment | |
| US20070135874A1 (en) | Endoscope for therapeutic light delivery | |
| CN102481086A (en) | Video laryngoscope system and devices | |
| CN106794248A (en) | The method of work of Ray mechanics therapy composition, method for disinfection, disinfection system and disinfection system | |
| US20070203550A1 (en) | Method and apparatus for application of light to tissue | |
| US20240042180A1 (en) | Method and apparatus for treating genitourinary problems | |
| CN116726408A (en) | Laser system for treating chest and abdomen infection and application method thereof | |
| US20240058483A1 (en) | Anti-microbial blue light systems and methods | |
| JPWO2004047875A1 (en) | Electromagnetic irradiation device | |
| EP3398499B1 (en) | Infection detection devices | |
| CA3172543A1 (en) | Internal ultraviolet therapy | |
| TWI675136B (en) | Light-guiding and tissue-integrated biofiber components | |
| RU2329787C2 (en) | Method of treatment of urethra iatrogenic infection caused by transurethral manipulations | |
| US10338310B2 (en) | Light transmittable and tissue integrable biofiber device | |
| Chen et al. | Lung tissue flap repairs esophagus defection with an inner chitosan tube stent | |
| CN108463249A (en) | The working method of Ray mechanics therapy composition, therapy, disinfection system and disinfection system | |
| JP4247446B2 (en) | Internal site light emitting device | |
| JP4164579B2 (en) | Internal site light emitting device | |
| WO2024098056A2 (en) | System and method for controlling against or treating of tympanostomy tube infections | |
| KR101576113B1 (en) | Ultraviolet device for human internal tissue | |
| RU89956U1 (en) | DEVICE FOR CONNECTING LASER RADIATION TO TISSUES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |